Sanno reinvests in Fellow Health – a male reproductive services company

Sanno extends its partnership with innovative male health company from San Francisco

  • Sanno participates in C round and continues to be one of Fellow Health’s biggest investors.
  • With this round of investments Fellow Health will advance their cryopreservation and sperm analysis as well as inhouse research.

    Munich, February 25, 2021 Fellow Health, a health care provider for men, from San Francisco received another round of investments from Sanno Capital.
    Fellow Health, headquartered in San Francisco is a male reproductive services company. The Financing C round enables the company to increase their clinical market share by expanding their sales team. They also plan to launch cryopreservation to advance their sperm analysis and with that advance their inhouse research.
    Currently doctors can test male fertility with Fellow Health´s testing kits easily from their practice, providing their patients with a more convenient and time-efficient solution to become reliable results.
    “Since the early days, Florian Moerth with Sanno Capital has been involved in financing Fellow Health. We are excited to extend and increase our partnership and look forward to tackle the greatest challenges in male reproductive health”, says William Matthews, Founder and CEO of Fellow Health.
    “Fellow Health provides a very important service in this regard”, concludes Florian Moerth, founder, and owner of Sanno Capital and one of Fellow Health´s biggest investors. “I am very happy to see this company grow even further and expand their business in the coming years”, Florian adds.
    About Fellow Health
    Since launching in April 2020, Fellow and it’s CLIA-approved laboratory has become one of the largest clinical semen analysis laboratories in the U.S. With the recent clinical validation of its at-home, mail-in male fertility diagnostic, the male reproductive sciences company is set to revolutionize the testing process, experts say, by offering a viable alternative to in-person sample generation at a laboratory.
    About Sanno Capital
    At Sanno Capital, we recognize tomorrow’s problem solvers and help them turn bright ideas into world-changing companies. Embedded in a top-class network of venture capital experts, we support founders with capital, expertise and contacts. Sanno Capital is one of Germany’s leading venture capital firms focusing on impact investment in the areas of healthcare, technology and mobility. The core objective of Sanno Capital is to invest in companies and founders who want to solve the social and ecological problems of our time and thereby improve the quality of life of mankind.<br /> The active portfolio includes companies such as Konux, Oura and Bird. Sanno Capital was founded in 2014 by Florian Moerth. Over the past ten years, Sanno Capital has facilitated both early and late stage investments for a variety of companies.<br /> Further information:

    Press Contact
    Petra Schmidt
    Personal Assistant

    Looping Group
    Maria Molody